Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses

Immunotherapy with check-point inhibitors (CPI) in adult malignancies: a protocol for the systematic review of the quality of economic analyses

Abstract Background Immuno-oncology, and in particular, check-point inhibitors (CPIs), have led to a paradigm shift in the field of cancer care. The cost of new drug development is high, and many novel agents in oncology are significantly more expensive than older agents. Therefore, healthcare funde...

Full description

Bibliographic Details
Main Authors: Ying Wang, Pierre Camateros, Denise Smith, David Dawe, Peter Ellis
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Systematic Reviews
Subjects:
Immuno-therapy
Immune-oncology
Check-point inhibitor
Economic analysis
Cost-effectiveness
Cancer
Online Access:http://link.springer.com/article/10.1186/s13643-019-1047-z

Internet

http://link.springer.com/article/10.1186/s13643-019-1047-z

Similar Items